Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men

We aimed to compare infection rates for two 3-day antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy (TRUSgbp) and demonstrate local microbiological trends. In 2008, 558 men and, in 2009, 625 men had TRUSgpb. Regimen 1 (2008) comprised 400 mg Ofloxacin immediately befo...

Full description

Saved in:
Bibliographic Details
Main Authors: Rustom P. Manecksha, Gregory J. Nason, Ivor M. Cullen, Jérôme P. Fennell, Elizabeth McEvoy, Ted McDermott, Robert J. Flynn, Ronald Grainger, John A. Thornhill
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/650858
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558331454029824
author Rustom P. Manecksha
Gregory J. Nason
Ivor M. Cullen
Jérôme P. Fennell
Elizabeth McEvoy
Ted McDermott
Robert J. Flynn
Ronald Grainger
John A. Thornhill
author_facet Rustom P. Manecksha
Gregory J. Nason
Ivor M. Cullen
Jérôme P. Fennell
Elizabeth McEvoy
Ted McDermott
Robert J. Flynn
Ronald Grainger
John A. Thornhill
author_sort Rustom P. Manecksha
collection DOAJ
description We aimed to compare infection rates for two 3-day antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy (TRUSgbp) and demonstrate local microbiological trends. In 2008, 558 men and, in 2009, 625 men had TRUSgpb. Regimen 1 (2008) comprised 400 mg Ofloxacin immediately before biopsy and 200 mg 12-hourly for 3 days. Regimen 2 (2009) comprised Ofloxacin 200 mg 12-hourly for 3 days commencing 24 hours before biopsy. 20/558 (3.6%) men had febrile episodes with regimen 1 and 10/625 (1.6%) men with regimen 2 (𝑃=0.03). E. coli was the most frequently isolated organism. Overall, 7/13 (54%) of positive urine cultures were quinolone resistant and (5/13) 40% were multidrug resistant. Overall, 5/9 (56%) patients with septicaemia were quinolone resistant. All patients were sensitive to Meropenem. There was 1 (0.2%) death with regimen 1. Commencing Ofloxacin 24 hours before TRUSgpb reduced the incidence of febrile episodes significantly. We observed the emergence of quinolone and multidrug-resistant E. coli. Meropenem should be considered for unresolving sepsis.
format Article
id doaj-art-97f304968a7248009bb895690d9a841e
institution Kabale University
issn 1537-744X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-97f304968a7248009bb895690d9a841e2025-02-03T01:32:44ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/650858650858Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 MenRustom P. Manecksha0Gregory J. Nason1Ivor M. Cullen2Jérôme P. Fennell3Elizabeth McEvoy4Ted McDermott5Robert J. Flynn6Ronald Grainger7John A. Thornhill8Department of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Microbiology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandDepartment of Urology, Adelaide and Meath Hospital, Tallaght, Dublin 24, IrelandWe aimed to compare infection rates for two 3-day antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy (TRUSgbp) and demonstrate local microbiological trends. In 2008, 558 men and, in 2009, 625 men had TRUSgpb. Regimen 1 (2008) comprised 400 mg Ofloxacin immediately before biopsy and 200 mg 12-hourly for 3 days. Regimen 2 (2009) comprised Ofloxacin 200 mg 12-hourly for 3 days commencing 24 hours before biopsy. 20/558 (3.6%) men had febrile episodes with regimen 1 and 10/625 (1.6%) men with regimen 2 (𝑃=0.03). E. coli was the most frequently isolated organism. Overall, 7/13 (54%) of positive urine cultures were quinolone resistant and (5/13) 40% were multidrug resistant. Overall, 5/9 (56%) patients with septicaemia were quinolone resistant. All patients were sensitive to Meropenem. There was 1 (0.2%) death with regimen 1. Commencing Ofloxacin 24 hours before TRUSgpb reduced the incidence of febrile episodes significantly. We observed the emergence of quinolone and multidrug-resistant E. coli. Meropenem should be considered for unresolving sepsis.http://dx.doi.org/10.1100/2012/650858
spellingShingle Rustom P. Manecksha
Gregory J. Nason
Ivor M. Cullen
Jérôme P. Fennell
Elizabeth McEvoy
Ted McDermott
Robert J. Flynn
Ronald Grainger
John A. Thornhill
Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
The Scientific World Journal
title Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
title_full Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
title_fullStr Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
title_full_unstemmed Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
title_short Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
title_sort prospective study of antibiotic prophylaxis for prostate biopsy involving 1100 men
url http://dx.doi.org/10.1100/2012/650858
work_keys_str_mv AT rustompmanecksha prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT gregoryjnason prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT ivormcullen prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT jeromepfennell prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT elizabethmcevoy prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT tedmcdermott prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT robertjflynn prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT ronaldgrainger prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men
AT johnathornhill prospectivestudyofantibioticprophylaxisforprostatebiopsyinvolving1100men